SAN FRANCISCO (AP) _ Audentes Therapeutics Inc. (BOLD) on Tuesday reported a loss of $31.4 million in its second quarter.

The San Francisco-based company said it had a loss of 85 cents per share.

The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 78 cents per share.

Audentes Therapeutics shares have increased 22 percent since the beginning of the year. The stock has increased 90 percent in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on BOLD at

blog comments powered by Disqus